What is the milligram dosage of buccal Cytotec (misoprostol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Buccal Cytotec (misoprostol) is typically administered in doses ranging from 200 to 800 mcg (0.2 to 0.8 milligrams) for various medical indications, with 200-400 mcg (0.2-0.4 mg) being common for labor induction or abortion procedures, as supported by studies such as 1. When considering the administration of buccal Cytotec, it's essential to understand that the medication is available in 200 microgram (mcg) tablets, which equals 0.2 milligrams per tablet.

  • The buccal route provides more gradual absorption than oral administration while avoiding first-pass metabolism in the liver, resulting in more sustained blood levels of the medication, as noted in 2.
  • This route is preferred in certain situations because it offers better bioavailability than swallowing the tablet while being less invasive than vaginal administration.
  • Always follow your healthcare provider's specific dosing instructions, as the appropriate amount varies based on your medical condition and treatment goals. Key points to consider include:
  • The efficacy of buccal misoprostol for cervical ripening, as compared to intravaginal administration, has been studied, with findings indicating that buccal misoprostol is effective but may result in a higher incidence of tachysystole, as seen in 1.
  • The safety and efficacy of misoprostol for various obstetric indications, including labor induction and abortion, have been evaluated in multiple studies, such as 3 and 4, highlighting the importance of careful dosing and administration.
  • The optimal dose and route of administration of misoprostol can vary depending on the specific clinical application and individual patient factors, as discussed in 5.

References

Research

Buccal versus intravaginal misoprostol administration for cervical ripening.

American journal of obstetrics and gynecology, 2002

Research

Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007

Research

Vaginal misoprostol for cervical ripening and induction of labour.

The Cochrane database of systematic reviews, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.